Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
The application of STING agonists and the blockade of the SIRPα–CD47 signaling axis are emerging immunotherapeutic strategies. Here the authors show that hybrid cellular membrane nanovesicles loaded with a STING agonist or overexpressing high-affinity SIRPα variants can be exploited to promote anti-...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/f17de9f800584c86b4d4c951356870bb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!